CT lung cancer screening turns out to be like many new medical technologies: It improves health but is quite expensive. Moreover, it needs implementation that targets those most likely to benefit and provides them the care they need efficiently.
The possible effects of families on health and mortality is an extremely complex topic. No single study or type of study is exactly a test of the argument. We need more studies that advance possible interpretations and describe patterns of associations in broad populations of interest.
Despite high per-capita expenditures in the U.S., Americans under the age of 65 are less likely than their peers in France, Germany, or the United Kingdom to receive timely and appropriate health care, writes Ellen Nolte.
Outlines a roadmap toward a comprehensive monitoring system that national and regional decisionmakers can use to track progress toward World Health Organization goals to reduce the global burden of noncommunicable diseases.
While Americans aged 55 to 64 have higher rates of chronic diseases than their peers in England, they die at about the same rate. And Americans age 65 and older—while still sicker than their English peers—have a lower death rate than similar people in England.